Skip to main content

Table 1 Summary of the results from 29 included articles identified in a systematic review of the literature

From: Ovarian function and reproductive outcome after ovarian tissue transplantation: a systematic review

Study design

Participants underwent ovarian tissue transplantation

Intervention

Time of procedure

Follow up (median range)

Outcome(s)

(Author, year)

Case report

A woman with diagnose of anal cancer

Auto-transplantation/frozen tissue

30.5 years

225 days

Ovarian function by follicle growth and FSH, LH and E2

Dittrich et al. 2008 [15]

Technical note

A woman with diagnose of Hodgkin disease and relapse

Auto-transplantation/frozen tissue

33 years

Not reported

Ovarian function, fertility and pregnancy

Dittrich et al. 2012 [16]

Retrospective analysis

11 women with hematological malignancy, four with Brest cancer, tree with anal cancer and two with ovarian cancer

Auto-transplantation/frozen tissue

Mean age 34.2 years

Ongoing to date of study

Ovarian function and pregnancy

Dittrich et al. 2015 [17]

Case report

A woman with diagnose of Hodgkin’s lymphoma

Auto-transplantation/frozen tissue

32 years

1 year

Ovarian activity with FSH, E2 and LH, fertility

Muller et al. 2012 [18]

Case report

A woman with diagnose of primary Sjogren’s syndrome

Auto-transplantation/frozen tissue

42 years

244 days

Follicular development

Wølner-Hanssen et al. 2005 [19]

Case report

A woman with diagnose of invasive ductal breast carcinoma

Auto-transplantation/frozen tissue

44 years

7 months

Ovarian function by hormonal assay and follicular development, pregnancy

Burmeister et al. 2013 [20]

Case report

A woman with diagnose of b-thalassemia

Auto-transplantation/frozen tissue

29 years

12 months

Restoration of ovarian function, pregnancy, and live birth

Revelli et al. 2013 [21]

Case report

A woman with papillary thyroid carcinoma and metastases of neck lymph node

Auto-transplantation/frozen tissue

26 years

2 years

Ovarian function by FSH, LH, E2 and AMH and pregnancy

Kiseleva et al. 2015 [22]

Case report

A woman with diagnose of sickle-cell anemia

Auto-transplantation/frozen tissue

27 years

4 years

Ovarian function by hormonal level, follicular development and menstrual cycle, pregnancy and live birth

Demeestere et al. 2015 [10]

Case report

A woman with diagnose of Ewing’s sarcoma

Auto-transplantation/frozen tissue

28 years

5 years

Pregnancy and live birth

Ernst et al. 2010 [23]

Case report

A woman with Hodgkin lymphoma

Auto-transplantation/frozen tissue

30.5 years

5 years

Restoration of ovarian function, fertility and pregnancy outcome

Oktay et al. 2011 [24]

Prospective cohort

A woman with thalassemia

Auto-transplantation/frozen tissue

29 years

6.5 years

Gonadal function by FSH, AMH and E2 levels

Biasin et al. 2015 [25]

Prospective cohort

Four women aged 46–49 year with abdominal hysterectomy and bilateral salpingo oophorectomy for uterine leiomyomas

Auto-transplantation/fresh and frozen tissue

46–49 years

1 year

Ovarian function by serum E2 and FSH and follicular growth

Callejo et al. 2001 [26]

Case report

Three patient of 20, 15 and 12-year old women with diagnose of β-thalassemia major, homozygous sickle cell anemia and AML, respectively underwent chemotherapy and TBI before BMT

Allo-transplantation/fresh tissue

Respectively 35, 32, 32

1 year

Ovarian function by hormonal level and follicular development

Donnez et al. 2010 [27]

Prospective cohort

Three women were included; a 23-years old woman with colorectal cancer dukes b2, 34 years old woman with infiltrating lobular carcinoma and 29 years old woman with Hodgkin’s lymphoma, mixed-cellularity sub-type

Auto-transplantation/frozen tissue

31, 41 and 39 years

91 Weeks

Ovarian function by hormonal assessment, ultrasound examination and follicular development

Fabbri et al. 2014 [28]

Prospective cohort

10 women with Hodgkin’s lymphoma, sickle cell anemia, Hodgkin’s lymphoma, non-Hodgkin lymphoma, Wegener’s granulomatosis, cerebral tumor, tubo-ovarian abscess, endometriosis, major-thalassemia, AML, sickle cell anemia

Auto and allo-transplantation/fresh and frozen tissue

24–35 years

2.5 years

Ovarian function analyzed by systemic levels of FSH, LH, inhibin B, E2, and AMH

Janse et al. 2011 [29]

Retrospective cohort

41 women with breast cancer, Mb. Hodgkin, non-Hodgkin, cervical cancer, aplastic anaemia, Ewing sarcoma, paroxysmal nocturnal, Haemoglobinuria sarcoma, Haemolytic uraemic syndrome, ovarian cancer, colon cancer, anal cancer and others

Auto-transplantation/frozen tissue

Mean age: 32.9 years

10 years

Ovarian function and fertility outcome

Jensen et al. 2015 [30]

Prospective cohort

Five women presented with cervical cancer (3), breast cancer (1), and Hodgkin’s lymphoma (1)

Auto-transplantation/frozen tissue

Mean age 31

7 years

Ovarian function by (FSH, LH, estradiol, progesterone, and testosterone, follicular growth by ultrasound

Kim 2012 [31]

Retrospective cohort

A woman at the age of 28 with B cell non-Hodgkin’s lymphoma

Auto-transplantation/frozen tissue

One 31-year-old patient

30 months

Ovarian activity by hormonal assay and follicular growth

Meirow et al. 2007 [32]

Case report

A woman with mature cystic teratoma and underwent right salpingo-oophorectomy

Auto-transplantation/frozen tissue

34 years old

4 years ongoing

Ovarian function by hormonal level and Doppler ultrasound

Fabbri et al. 2018 [33]

Prospective cohort

20 cancer survivors’ women with CML, Hodgkin’s, Breast cancer, non-Hodgkin’s lymphoma, Ewing’s sarcoma and AML developed into POF

Auto-transplantation/frozen tissue

22–45 years

7 to 141 months

Endocrine profile, IVF, pregnancies, live births

Meirow et al. 2016 [34]

Prospective cohort

10 pairs of identical twin sisters out of which one sister of each pair diagnosed with POF received ovarian transplants from other normal sister also another woman whom received her own cryopreserved ovarian tissue at the time of transplantation

Auto and Allo-transplantation/fresh and frozen tissue

24–40 years

5 years

Menstrual cycle, hormone levels, pregnancy, live birth, duration of transplant function, and ovarian tissue evaluation

Silber et al. 2010 [35]

Prospective cohort

17 infertile women with POI

Auto-transplantation/frozen tissue

ND

Not reported

Follicle growth, serum estrogen level and IVF-embryo transfer

Suzuki et al. 2015 [36]

Retrospective cohort

Two patients with T cell lymphoma and Hodgkin lymphoma

Auto-transplantation/frozen tissue

24 and 22 years

40 months

Ovarian function by FSH and AMH and pregnancy

Tanbo et al. 2015 [37]

Retrospective cohort

38 women with hematologic neoplasia (17); with breast carcinoma (10); borderline ovarian cancer and tumor (4), anal cancer (3); premature ovarian failure (2); ovarian cancer (1) and cervical cancer (1)

Auto-transplantation/frozen tissue

27–44 years

8 years

Ovarian function confirmed by hormonal analysis, onset of menstrual cycle or elevation of systemic levels of estradiol

Beckmann et al. 2017 [38]

Case report

One 24 years old patient with diagnose of Hodgkin’s disease stage iv

Auto-transplantation/frozen tissue

29 years

267 days

FSH, LH, Follicle count and pregnancy

Demeestere et al. 2006 [39]

Retrospective cohort

Eight women diagnosed with cancer followed by POF underwent ovarian tissue transplantation for fertility

Auto-transplantation/frozen tissue

22–39 years

7 years

Ovarian function and fertility

Imbert et al. 2014 [40]

Case report

A woman at the age of 18 with acute severe pelvic pain

Auto-transplantation/frozen tissue

28 years

8 months

Serum estradiol and FSH, follicular development and pregnancy outcome

Povoa et al. 2016 [41]

Prospective cohort

22 patients include 11 POF and 11 cancer patients with Hodgkins, brain cancer, MS, Blood Disorder, Synovial sarcoma and breast cancer

Auto and allo-transplantation/fresh and frozen tissue

ND

In 19 with over 1-year follow-up and in other 240 days

Ovarian function by FSH, LH, estradiol, AMH, and menstrual cycle

Silber et al. 2015 [11]

  1. AML acute myeloid leukemia ALL acute lymphoid leukemia CML chronic myeloid leukemia TBI total body irradiation BMT bone marrow transplantation, POF premature ovarian failure, POI premature ovarian insufficiency, HSCT hematopoietic stem cell transplantation, FSH follicle stimulating hormone, LH Luteinizing hormone; AMH anti-Mullerian hormone E2 estradiol ND not determined